Recovery from neuroendocrinological abnormalities and frontal hypoperfusion after remission in a case with rapid cycling bipolar disorder

Psychiatry and Clinical Neurosciences

Volumn 51, Issue 4, 1997, Pages 207-212

  Shimizu, Eiji ^a   Kodama, Kazuhiro ^a   Sakamoto, Tadashi ^b   Komatsu, Naoya ^a   Yamanouchi, Naoto ^a   Okada, Shin Ichi ^a   Sato, Toshio ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Chiba Municipal Hospital   (Japan)

Author keywords

Bipolar disorder; Clonazepam; Dexamethasone suppression test; Hypothyroidism; Rapid cycling affective disorder; Single photon emission computed tomography

Indexed keywords

17 OXOSTEROID; ACETAZOLAMIDE; AMITRIPTYLINE; ANDROSTERONE; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; DEXAMETHASONE; ETIOCHOLANOLONE; FLUORODEOXYGLUCOSE F 18; HYDROCORTISONE; IMIPRAMINE; IOFETAMINE I 123; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM CARBONATE; NEUROLEPTIC AGENT; PROLACTIN; PROTIRELIN; THYROTROPIN; THYROXINE; VALPROIC ACID; ZOTEPINE;

ADULT; ARTICLE; BRAIN; BRAIN BLOOD FLOW; CASE REPORT; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HAMILTON SCALE; HUMAN; HYPOTHYROIDISM; MANIC DEPRESSIVE PSYCHOSIS; NEUROENDOCRINE DISEASE; ORAL DRUG ADMINISTRATION; RADIOIMMUNOASSAY; REMISSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030811620     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.1997.tb02584.x     Document Type: Article

References (34)

1. Dunner DL, Fieve RR. Clinical factors in lithium prophylaxis failures. Arch. Gen. Psychiatry 1974; 30: 229-233.
2. Roy-Byrne PP, Joffe RT, Uhde TW, Post RM. Approaches to the evaluation and treatment of rapid cycling affective illness. Br. J. Psychiatry 1984; 145; 543-550.
3. Bauer MS, Whybrow PC, Winokur A. Rapid cycling bipolar affective disorder: I. Association with grade I hypothyroidism. Arch. Gen. Psychiatry 1990; 47: 427-434.
4. Cowdry RW, Wehr TA, Zis AP, Goodwin FK. Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch. Gen. Psychiatry 1983; 40: 414-420.
5. George MS, Ketter TA, Post RM. SPECT and PET imaging in mood disorders. J. Clin. Psychiatry 1993; 54 (Suppl. ): 6-13.
6. Chouinard G, Young SN, Annable L. Antimanic effect of clonazepam. Biol. Psychiatry 1983; 18: 451-466.
7. Chouinard G. Clonazepam in acute and maintenance treatment of bipolar affective disorder. J. Clin. Psychiatry 1987; 48 (Suppl. 10): 29-36.
8. Chouinard G. The use of benzodiazepines in the treatment of manic-depressive illness. J. Clin. Psychiatry 1988; 49 (Suppl. 11): 15-19.
9. Hamilton MA. Development of a rating scale for primary depressive illness. Br. J. Clin. Psychol. 1967; 6: 278-296.
10. Gold MS, Pottash ALC, Extein I. Hypothyroidism and depression: Evidence from a complete thyroid function evaluation. JAMA 1981; 245: 1919-1922.
11. Yamaguchi T, Nomura J, Hatotani N. Thyroid treatment and thyroid function in depression. In: Hatotani N, Nomura J (eds.). Neurobiology of Periodic Psychoses. Igaku Shoin, Tokyo, 1983; 127-138.
12. Haggerty JJ, Stern RA, Mason GA, Beckwith J, Morey CE, Prange AJ Jr. Subclinical hypothyroidism: A modifiable risk factor for depression? Am. J. Psychiatry 1993; 150: 508-510.
13. Hatotani N, Ishida C, Yura R et al. Psychophysiological studies of atypical psychoses: Endocrinological Aspect of Periodic Psychoses. Folia Psychiat. Neurol Jpn. 1962; 16: 248-292.
14. Carroll BJ, Feinber G M, Greden JF et al. A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Arch. Gen. Psychiatry 1981; 38: 15-22.
15. Targum SD. Persistent neuroendocrine dysregulation in major depressive disorder: A marker for early relapse. Biol. Psychiatry 1984; 19: 305-318.
16. Ribeiro SCM, Tandon R, Grunhaus L, Greden JF. The DST as a predictor of outcome in depression: A meta-analysis. Am. J. Psychiatry 1993; 150: 1618-1629.
17. Brady KT, Anton RF. The thyroid axis and desipramine treatment in depression. Biol. Psychiatry 1989; 25: 703-709.
18. Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder: II. Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study. Arch Gen Psychiatry 1990; 47: 435-440.
19. Stancer HC, Persad E. Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch. Gen. Psychiatry 1982; 39: 311-312.
20. Chevalier JF, Glück N, Marcel E, Habert MO. SPECT et pseudo démence dépressive: A propos d'un cas. L'Encépale 1992; 18: 647-650 (in French).
21. Coppen A, Abou-Saleh MT. Lithium therapy: From clinical trials to practical management. Acta Psychiat. Scand. 1988; 78: 297-301.
22. Bartalena L, Pellegrini L, Meschi M et al. Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder. Psychiatry Res. 1990; 34: 13-17.
23. von Bardeleben U, Wiedemann K, Stalla GK, Müller OA, Holsboer F. Exaggerated corticotrophic cell response to human corticotropin-releasing hormone in two patients during long-term carbamazepine treatment. Biol. Psychiatry 1988; 24: 331-335.
24. Nomura J, Hatotani N, Hisamitsu K, Higashimura T, Kamiya S. Studies on the cerebrohapatic relationship with reference to the pathogenesis of acute psychoses. In: Hatotani N, Nomura J (eds). Neurobiology of Periodic Psychoses. Igaku Shoin, Tokyo, 1983; 201-214.
25. Ribeiro SCM, Tandon R, Grunhaus L, Greden JF. The DST as a predictor of outcome in depression: A meta-analysis. Am. J. Psychiatry 1993; 150: 1618-1629.
26. Sapolsky RM, Pulsinelli WA. Glucocorticoids potentiate ischemic injury to neurons: Therapeutic implications. Science 1985; 229: 1397-1400.
27. McEwen BS, Angulo J, Cameron H et al. Paradoxical effects of adrenal steroids on the brain: Protection versus degeneration. Biol Psychiatry 1992; 31: 177-199.
28. Baxter LR, Phelps ME, Mazziotta JC et al. Cerebral metabolic rates for glucose in mood disorders: Studies with positron emission tomography and fluorodeoxyglucose F18. Arch. Gen. Psychiatry 1985; 42: 441-447.
29. Baxter LR, Schwartz JM, Phelps ME et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry 1989; 46: 243-250.
30. Martinet JL, Hardy P, Feline A et al. Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am. J. Psychiatry 1990; 147: 1313-1317.
31. Bench CJ, Frackowiak RSJ, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol. Med. 1995; 25: 247-251.
32. Berman KF, Doran AR, Pickar D, Weinberger DR. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Br. J. Psychiatry 1993; 162: 183-192.
33. Kodama K, Okada S, Hino T et al. Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J. Neurol. Neurosurg. Psychiatry 1995; 58: 307-311.
34. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. N. Engl. J. Med. 1988; 319: 413- 420.